```html

Exophthalmos (Bulging Eyes)

What is Exophthalmos (bulging eyes)?

Exophthalmos, also called proptosis, is the abnormal forward displacement of one or both eyeballs out of the orbit. The eyes may appear “stuck out,” may feel uncomfortable, and can be associated with changes in vision or eye movement. The condition results from increased volume behind the eye (e.g., inflamed tissue, tumor, fluid) that pushes the globe forward.

While a mild, chronic bulging may be detected only on a routine eye exam, severe exophthalmos can lead to exposure keratopathy (dry cornea), optic nerve compression, and even loss of vision if left untreated.

Key point: Exophthalmos is a sign, not a disease itself. Identifying the underlying cause is essential for appropriate management.

Common Causes

More than a dozen conditions can produce exophthalmos. The most frequent etiologies include:

• Graves’ disease (thyroid eye disease) – Autoimmune inflammation of the orbital tissues is the leading cause of bilateral exophthalmos.
• Orbital cellulitis – Bacterial infection of the orbital contents that causes swelling and pus formation.
• Orbital tumors – Benign (e.g., cavernous hemangioma) or malignant (e.g., lymphoma, metastasis) growths.
• Vascular malformations – Carotid‑cavernous fistula or arteriovenous malformations can increase orbital pressure.
• Trauma – Fractures of the orbital bone or retro‑orbital hemorrhage push the eye forward.
• Inflammatory diseases – Sarcoidosis, Wegener’s granulomatosis, or idiopathic orbital inflammation.
• Hyperthyroidism without Graves’ disease – Rarely, excess thyroid hormone itself can cause mild proptosis.
• Congenital or developmental anomalies – E.g., microphthalmia‑associated orbital enlargement.
• Systemic diseases with orbital edema – Nephrotic syndrome, severe liver disease, or congestive heart failure.
• Medications – Certain drugs (e.g., isotretinoin, amiodarone) have been reported to cause orbital swelling.

Associated Symptoms

Exophthalmos often does not occur in isolation. Common accompanying features include:

• Dryness, gritty sensation, or burning of the eyes (exposure keratopathy).
• Redness and conjunctival irritation.
• Double vision (diplopia) due to extra‑ocular muscle involvement.
• Pain or pressure around the eyes, especially when moving the eyes.
• Swelling of the eyelids (eyelid retraction) and/or lid lag.
• Difficulty closing the eyes completely (lagophthalmos).
• Changes in visual acuity or peripheral vision loss.
• Graves’ disease patients may have systemic signs: weight loss, heat intolerance, tremor, goiter.
• Fever, facial swelling, or sinus pain if infection is present.

When to See a Doctor

Because exophthalmos can rapidly threaten vision, prompt medical evaluation is warranted when any of the following occur:

• Sudden onset or rapid progression of eye bulging.
• Severe eye pain, especially with movement.
• New or worsening double vision.
• Decreased visual acuity, field loss, or color vision changes.
• Redness, swelling, or discharge suggestive of infection.
• Inability to fully close the eyelids (risk of corneal ulceration).
• Accompanying systemic symptoms such as fever, weight loss, or thyroid abnormalities.

Even if the bulging is chronic and painless, an eye‑care professional should evaluate it to rule out underlying disease and to establish a monitoring plan.

Diagnosis

Diagnosing exophthalmos involves a combination of clinical assessment, imaging, and laboratory tests.

1. Clinical Examination

• Hertel exophthalmometer – Measures the distance (mm) between the lateral orbital rim and the anterior surface of the cornea. Normal values are 12‑21 mm; a difference >2 mm between eyes is considered significant.
• Assessment of eye movement, eyelid position, corneal staining (fluorescein), and visual acuity.
• Palpation for tenderness, masses, or crepitus.

2. Imaging Studies

• CT scan (computed tomography) – Excellent for evaluating bony orbit, detecting fractures, abscesses, and calcified lesions.
• MRI (magnetic resonance imaging) – Superior for soft‑tissue detail, orbital inflammation, and vascular malformations.
• Ultrasound of the orbit – Useful for quick bedside assessment of cystic vs solid lesions.

3. Laboratory Tests

• Thyroid function tests (TSH, free T4, T3) and thyroid‑stimulating immunoglobulins for Graves’ disease.
• Complete blood count (CBC) and inflammatory markers (CRP, ESR) if infection or systemic inflammation is suspected.
• Specific serologies (e.g., ANCA for Wegener’s, ACE for sarcoidosis) based on clinical suspicion.

4. Specialist Referral

Ophthalmology, endocrinology, otolaryngology, or neurosurgery may be involved, depending on the suspected cause.

Treatment Options

Treatment is directed at the underlying cause and at protecting the eye surface and optic nerve. Approaches can be grouped into medical, surgical, and supportive measures.

Medical Management

• Thyroid eye disease – First‑line is high‑dose oral glucocorticoids or intravenous methylprednisolone to reduce inflammation. In refractory cases, disease‑modifying agents such as teprotumumab (an IGF‑1R inhibitor) have shown benefit (FDA approved 2020). Mayo Clinic.
• Orbital cellulitis – Empiric broad‑spectrum IV antibiotics (e.g., vancomycin + ceftriaxone) until culture results guide therapy. Hospitalization is often required.
• Inflammatory orbital disease – Systemic steroids, sometimes followed by a steroid‑sparing agent (azathioprine, mycophenolate) to prevent recurrence.
• Infections (e.g., fungal) – Antifungal agents such as amphotericin B, often combined with surgical debridement.
• Neoplastic lesions – Treatment varies: observation for benign lesions, radiation or chemotherapy for malignant tumors, and surgical excision when feasible.

Surgical Interventions

• Orbital decompression surgery – Removes bone and/or fat from the orbit to create more space, frequently performed for severe Graves’ eye disease or after trauma.
• Lacrimal or eyelid procedures – Can correct lagophthalmos and protect the cornea (e.g., lateral canthoplasty, punctal plugs).
• Drainage of abscess – Indicated for orbital cellulitis with a well‑formed collection.
• Tumor resection – Requires multidisciplinary planning (neurosurgery, ENT, oncology).

Home & Supportive Care

• Artificial tears or lubricating ointments at least 4–6 times daily to prevent corneal drying.
– Use a humidifier in dry environments.
• Sleep with the head elevated 30‑45° to reduce orbital edema.
• Protect the eyes with a soft eye shield at night if the lids cannot close fully.
• Smoking cessation – Smoking worsens Graves’ eye disease and impairs wound healing.
• Maintain optimal thyroid control with endocrinology follow‑up.

Prevention Tips

Because many causes are unavoidable (e.g., genetics, trauma), prevention focuses on modifiable risk factors and early detection:

• Manage underlying thyroid disease promptly; keep TSH within target range.
• Seek early treatment for sinus infections or facial trauma to avoid spread to the orbit.
• Practice good eye hygiene; avoid rubbing eyes with dirty hands.
• Wear protective eyewear during sports, construction work, or any activity with a risk of facial injury.
• Control systemic inflammatory conditions (e.g., sarcoidosis, vasculitis) with regular follow‑up.
• Limit exposure to allergens and irritants that can exacerbate orbital tissue swelling.

Emergency Warning Signs

If you experience any of the following, seek emergency medical care (e.g., ED or urgent care) immediately:

• Sudden, severe eye pain with vision loss.
• Rapidly worsening bulging or protrusion of the eye.
• Double vision that appears suddenly or worsens.
• Swelling, redness, and fever suggesting orbital cellulitis.
• Inability to close the eye, leading to constant exposure of the cornea.
• Loss of color vision or a dark spot/shadow in part of the visual field.
• Signs of stroke or neurological deficit (e.g., facial weakness, slurred speech) accompanying eye changes.

These symptoms may indicate optic nerve compression, infection, or a vascular emergency that can cause permanent vision loss if not treated promptly.

---

**Sources**: Mayo Clinic, American Thyroid Association, National Eye Institute (NIH), Centers for Disease Control and Prevention (CDC), Cleveland Clinic, Journal of Clinical Endocrinology & Metabolism, Ophthalmology Science.

```